Showing results (1121-1130 of 1,142) with videos related to

Sort By:
Pageof 115
Cancer Letters|May 12, 2025
Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trialWen-Jia Zuo, Lin-Xiao-Xi Ma, Zhi-Hong Wang, et al.
Frontiers in Pharmacology|November 19, 2019
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer CellsYu-Shih Lin, Yi-Chia Shen, Ching-Yuan Wu, et al.
Emerging Microbes & Infections|July 19, 2022
A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variantsDan Wu, Ying Ye, Lin Tang, et al.
Chinese Medical Journal|January 4, 2007
Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, ChinaJian-qing Xu, Jian-jun Wang, Li-feng Han, et al.
Breast Cancer Research and Treatment|September 14, 2007
The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identifiedWen-Feng Li, Zhen Hu, Nan-Yan Rao, et al.
Bioorganic & Medicinal Chemistry|July 29, 2018
7β-Methyl substituent is a structural locus associated with activity cliff for nepenthone analoguesHui-Jiao Sun, Yu-Hua Wang, Cong-Min Yuan, et al.
Diabetologia|December 2, 2024
Metabolomics profiling in multi-ancestral individuals with type 2 diabetes in Singapore identified metabolites associated with renal function declineYuqing Chen, Federico Torta, Hiromi W L Koh, et al.
BMC Cancer|May 19, 2021
Genomic features of rapid versus late relapse in triple negative breast cancerYiqing Zhang, Sarah Asad, Zachary Weber, et al.
Breast Cancer Research and Treatment|April 25, 2012
A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients' persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancerKe-Da Yu, Ying Zhou, Guang-Yu Liu, et al.
JAMA|December 13, 2024
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer: The CamRelief Randomized Clinical TrialLi Chen, Hui Li, Hao Zhang, et al.
Pageof 115